Eric H Chang

I'm honored and excited to co-chair the 2026 Bioelectronic Medicine Summit, hosted by the Feinstein Institutes @NorthwellHealth! This September 28-29th, please join us at Chelsea Piers, NYC to hear from an exciting line-up of international speakers in the field. Abstract submissions are open NOW through May 15th, 2026. Hope to see you in New York! bemsummit.org

Bioelectronic medicine is one of the most promising products of neuroimmunology. This field is absolutely exploding now. You will not want to miss the 7th Bioelectronic Medicine Summit which will take place in NYC 9/28-9/29. Keynotes include @eboyden3 @mikhailshapiro courtesy of @NorthwellHealth bemsummit.org

1. More federal science funding should go directly to labs. 2. Science should be funded faster. 3. Scientists that convert federal funding to products (diagnostics, devices, and drugs) should be rewarded with more and faster #1 and #2. This alone would exponentially change outcomes for our patients. Currently, this is disproportionately delegated to philanthropic foundations.

When every moment matters, the right doctor can make all the difference. Northwell has the most Top Doctors than any health system in America, taking on more of New York’s toughest cases and training one of the largest groups of future physicians. Learn more: northwell.edu/topdoctors

Happy to share that former lab technician Timothy Morgan has just started @UMassChan in the MD/PhD program! Tim contributed on multiple projects in the lab and co-authored several papers, with more coming. The future of science looks bright!Good luck Tim!!

Some great ideas in the @asterainstitute essay competition! Thanks to @seemaychou for supporting it. I asked Claude to create a taxonomy of the public goods identified in the essays. These are resources that benefit the field, but not the individuals that create them. As Claude notes, “The reward system pays for novel positive claims, not for the connective tissue that makes the whole enterprise work.” Claude identified seven categories, such as negative results; capturing and documenting tacit and knowledge; the curation of data for reuse and recombination; standards for measurement and protocols; the format of scientific knowledge (e.g. not PDFs, but a machine-readable, queryable cumulative structure); and the ability to identify and pursue collective priorities. This suggests some new directions for what @michael_nielsen and @kanjun have called “metascience as design practice.” What are the tools, institutions, experiments, incentive structures that enable the identification, creation and maintenance of these public goods? How can we learn from the successful and failed efforts of different fields and sub-fields to support these public goods? How might we create new roles – such as the “research software engineers” that develop and maintain software on behalf of different research communities? What if funders explicitly allocated some share of their budgets to public goods? What are the tools that make it easier for people to contribute to these public goods? Link to the Claude summary in the reply.

Just a few weeks left to apply! 2026 Research Triangle #Miniscope Workshop, August 26–27, Durham, NC! This hands-on workshop covers the full Open-source Miniscope calcium imaging pipeline from theory to analysis. Deadline to apply is July 17: forms.gle/VqjwxouPhUYajN…

Congrats to postdoc @rofu47 on his 🔥paper out in @ImmunityCP. This gives strong internal conviction that bioelectronic med has many use cases & so much more to the vagus nerve! Activation of the auricular vagus nerve reflex suppresses airway infla... sciencedirect.com/science/articl…

Extremely excited to announce our first air-to-air kill of a flying moth by an autonomous micro-drone. This is a big step towards completely eradicating mosquitoes.

Prepping for the 7th BEM Summit at The Lighthouse, Chelsea Piers (Pier 61). Join us on Sept 28-29, 2026 to hear the latest in bioelectronic medicine! Early bird registration is still available now through Aug 7th. See you there!! bemsummit.org

Was a pleasure moderating this powerhouse team at @NorthwellHealth /Feinstein Institute. Big takeaway from the session was how under rated Northwell is given their facilities for efficiently maneuvering through discovery, development, and deployment of therapies.

The classic tension in science: PIs are rewarded for origin - being first, citations - while patients only care if something useful comes out of an idea. AI is so disruptive because, like patients, it doesn’t care who owns ideas. It only cares what works. How will we adapt?

At #CatalystNYC, Cliff Friedman, Founder and Managing Partner of @NorthwellHealth Equity Partners, will join a panel on accelerating the path from scientific discovery to clinical application. Drawing on decades in healthcare investing and innovation, he’ll share what it takes to bridge that gap. Request an invitation → luma.com/66yycaak

@hansonhuangsums @FeinsteinIMR @NorthwellHealth Congrats Hai!!

Excited to share that I have received an NIH NIGMS MIRA (R35) award! Grateful to my outstanding trainees, collaborators, and the incredible support from @FeinsteinIMR and @NorthwellHealth. #NIH #MIRA #FeinsteinInstitutesformedicalresearch

Renowned Physician-Scientist Brian S. Kim Joins Northwell as First Chief Biotechnology Officer - businesswire.com/news/home/2026…

Excited to share our new paper in @ScienceMagazine A subset of lung cancers drives cachexia, not through factors circulating in the blood, but through local lung sensory neurons. science.org/doi/10.1126/sc… big thanks to first authors Michael and @s_kotschi our collaborators

Today is my first day at Feinstein Institutes at @NorthwellHealth. I am joining the bioelectronic medicine and neuroimmunology legend @KevinJTraceyMD to make transformative changes not just to science and medicine, but how biotech can be done in an integrated healthcare system. Over the past 12 years, I’ve been lucky to work at the intersection of immunology, neuroscience, dermatology, allergy, and drug development inside major academic medical centers. That experience keeps revealing the same uncomfortable truth: our systems still struggle to support physician‑scientists who also build companies and turn ideas into products. My next chapter is about fixing that from a health‑system + biotech vantage point - treating IP as core strategy, building real bridges from lab to clinic, and intentionally cultivating the “weird” careers: founders, C‑suite physician‑scientists, translational obsessives. If you’re working on the next generation of biomedical ecosystems, I'd love to connect.

Our preprint in @CellCellPress Sneak Peek in @SSRN got a 99 on the @qedScience score @OdedRechavi. This was before revisions. The revised manuscript is now accepted at @ImmunityCP. Very interesting @rofu47!

@itchdoctor @IcahnMountSinai Congrats and welcome, Brian! Exciting times ahead!

After almost five meaningful years at the @IcahnMountSinai, I’ll be wrapping up my time here at the end of June and closing this chapter of my academic career. I’m deeply grateful to my colleagues, trainees, collaborators, and leaders at Mount Sinai for the opportunities to build programs together and push the science of neuroimmunology and care of inflammatory skin (and other) disease forward — it has been a privilege to grow alongside such a talented community. In July, I’ll be joining the Feinstein Institutes for Medical Research & @NorthwellHealth as the inaugural Chief Biotechnology Officer, focusing on building new bridges between discovery, clinical research, and biotech across the health system. I’m excited about the chance to help accelerate translational science at scale and to work with new partners across academia, industry, and venture. My lab will continue to focus on foundational science in neuroimmunology. More details soon. To everyone I’ve had the chance to work with so far — thank you. I’m looking forward to staying in touch, finding new ways to collaborate, and continuing to advance the field together from this new perch.

My favorite video I’ve ever taken. Absolutely surreal.